FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2461496717> ?p ?o ?g. }

• W2461496717 endingPage "156" @default.
• W2461496717 startingPage "156" @default.
• W2461496717 abstract "Substance use is a major driver of the HIV epidemic and is associated with poor HIV care outcomes. Patient navigation (care coordination with case management) and the use of financial incentives for achieving predetermined outcomes are interventions increasingly promoted to engage patients in substance use disorders treatment and HIV care, but there is little evidence for their efficacy in improving HIV-1 viral suppression rates.To assess the effect of a structured patient navigation intervention with or without financial incentives to improve HIV-1 viral suppression rates among patients with elevated HIV-1 viral loads and substance use recruited as hospital inpatients.From July 2012 through January 2014, 801 patients with HIV infection and substance use from 11 hospitals across the United States were randomly assigned to receive patient navigation alone (n = 266), patient navigation plus financial incentives (n = 271), or treatment as usual (n = 264). HIV-1 plasma viral load was measured at baseline and at 6 and 12 months.Patient navigation included up to 11 sessions of care coordination with case management and motivational interviewing techniques over 6 months. Financial incentives (up to $1160) were provided for achieving targeted behaviors aimed at reducing substance use, increasing engagement in HIV care, and improving HIV outcomes. Treatment as usual was the standard practice at each hospital for linking hospitalized patients to outpatient HIV care and substance use disorders treatment.The primary outcome was HIV viral suppression (≤200 copies/mL) relative to viral nonsuppression or death at the 12-month follow-up.Of 801 patients randomized, 261 (32.6%) were women (mean [SD] age, 44.6 years [10.0 years]). There were no differences in rates of HIV viral suppression versus nonsuppression or death among the 3 groups at 12 months. Eighty-five of 249 patients (34.1%) in the usual-treatment group experienced treatment success compared with 89 of 249 patients (35.7%) in the navigation-only group for a treatment difference of 1.6% (95% CI, -6.8% to 10.0%; P = .80) and compared with 98 of 254 patients (38.6%) in the navigation-plus-incentives group for a treatment difference of 4.5% (95% CI -4.0% to 12.8%; P = .68). The treatment difference between the navigation-only and the navigation-plus-incentives group was -2.8% (95% CI, -11.3% to 5.6%; P = .68).Among hospitalized patients with HIV infection and substance use, patient navigation with or without financial incentives did not have a beneficial effect on HIV viral suppression relative to nonsuppression or death at 12 months vs treatment as usual. These findings do not support these interventions in this setting.clinicaltrials.gov Identifier: NCT01612169." @default.
• W2461496717 created "2016-07-22" @default.
• W2461496717 creator A5000048763 @default.
• W2461496717 creator A5003642656 @default.
• W2461496717 creator A5006555256 @default.
• W2461496717 creator A5009013887 @default.
• W2461496717 creator A5010929283 @default.
• W2461496717 creator A5015290437 @default.
• W2461496717 creator A5018454019 @default.
• W2461496717 creator A5025707130 @default.
• W2461496717 creator A5027179036 @default.
• W2461496717 creator A5029718424 @default.
• W2461496717 creator A5032398444 @default.
• W2461496717 creator A5035170047 @default.
• W2461496717 creator A5035976485 @default.
• W2461496717 creator A5036998218 @default.
• W2461496717 creator A5037466690 @default.
• W2461496717 creator A5041987414 @default.
• W2461496717 creator A5042349349 @default.
• W2461496717 creator A5048198586 @default.
• W2461496717 creator A5048600560 @default.
• W2461496717 creator A5051310627 @default.
• W2461496717 creator A5067158518 @default.
• W2461496717 creator A5067438112 @default.
• W2461496717 creator A5072031668 @default.
• W2461496717 creator A5073223457 @default.
• W2461496717 creator A5076529428 @default.
• W2461496717 creator A5076551858 @default.
• W2461496717 creator A5080938279 @default.
• W2461496717 creator A5082238950 @default.
• W2461496717 creator A5083268031 @default.
• W2461496717 creator A5086984489 @default.
• W2461496717 creator A5089327163 @default.
• W2461496717 creator A5090456618 @default.
• W2461496717 date "2016-07-12" @default.
• W2461496717 modified "2023-10-16" @default.
• W2461496717 title "Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use" @default.
• W2461496717 cites W1859737084 @default.
• W2461496717 cites W1965554143 @default.
• W2461496717 cites W1975271154 @default.
• W2461496717 cites W1982624620 @default.
• W2461496717 cites W1985449809 @default.
• W2461496717 cites W1999629997 @default.
• W2461496717 cites W2002112331 @default.
• W2461496717 cites W2020285227 @default.
• W2461496717 cites W2021775209 @default.
• W2461496717 cites W2022273532 @default.
• W2461496717 cites W2024374498 @default.
• W2461496717 cites W2033051447 @default.
• W2461496717 cites W2035445723 @default.
• W2461496717 cites W2039184598 @default.
• W2461496717 cites W2041609381 @default.
• W2461496717 cites W2044229070 @default.
• W2461496717 cites W2046895647 @default.
• W2461496717 cites W2060860898 @default.
• W2461496717 cites W2099196535 @default.
• W2461496717 cites W2103217185 @default.
• W2461496717 cites W2149443374 @default.
• W2461496717 cites W2152358450 @default.
• W2461496717 cites W2154296640 @default.
• W2461496717 cites W2156258495 @default.
• W2461496717 cites W2172036914 @default.
• W2461496717 cites W2180038971 @default.
• W2461496717 cites W2184258190 @default.
• W2461496717 cites W2228001519 @default.
• W2461496717 cites W2235498348 @default.
• W2461496717 cites W2267891409 @default.
• W2461496717 cites W2416561957 @default.
• W2461496717 doi "https://doi.org/10.1001/jama.2016.8914" @default.
• W2461496717 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5339876" @default.
• W2461496717 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27404184" @default.
• W2461496717 hasPublicationYear "2016" @default.
• W2461496717 type Work @default.
• W2461496717 sameAs 2461496717 @default.
• W2461496717 citedByCount "144" @default.
• W2461496717 countsByYear W24614967172016 @default.
• W2461496717 countsByYear W24614967172017 @default.
• W2461496717 countsByYear W24614967172018 @default.
• W2461496717 countsByYear W24614967172019 @default.
• W2461496717 countsByYear W24614967172020 @default.
• W2461496717 countsByYear W24614967172021 @default.
• W2461496717 countsByYear W24614967172022 @default.
• W2461496717 countsByYear W24614967172023 @default.
• W2461496717 crossrefType "journal-article" @default.
• W2461496717 hasAuthorship W2461496717A5000048763 @default.
• W2461496717 hasAuthorship W2461496717A5003642656 @default.
• W2461496717 hasAuthorship W2461496717A5006555256 @default.
• W2461496717 hasAuthorship W2461496717A5009013887 @default.
• W2461496717 hasAuthorship W2461496717A5010929283 @default.
• W2461496717 hasAuthorship W2461496717A5015290437 @default.
• W2461496717 hasAuthorship W2461496717A5018454019 @default.
• W2461496717 hasAuthorship W2461496717A5025707130 @default.
• W2461496717 hasAuthorship W2461496717A5027179036 @default.
• W2461496717 hasAuthorship W2461496717A5029718424 @default.
• W2461496717 hasAuthorship W2461496717A5032398444 @default.
• W2461496717 hasAuthorship W2461496717A5035170047 @default.
• W2461496717 hasAuthorship W2461496717A5035976485 @default.
• W2461496717 hasAuthorship W2461496717A5036998218 @default.

• next